Silence Therapeutics prices upsized $175M ADS offering at $13.50 each — See source for full details.
$SLN
Price history, market instrument context, member research, and related headlines in one place.
SLN key statistics
NasdaqGMUSD
52-week range
$4.19100%$19.69
Latest session $19.65–$19.68Silence Therapeutics plc (SLN) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $19.67, up $0.01 (0.05%) from the previous close of $19.66. It has traded between $19.65 and $19.68 in the latest session. Over the past year it has ranged from $4.19 to $19.69, leaving it trading at the top of its 52-week range. Reported volume for the session was 2.1M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
WOOK AIASK ANYTHING · NEVER ADVISES
Meet Wook AI, your friendly assistant. Ask how something works, about any company, fund or coin, or have it do the math — live figures come from this site’s own lookups, and you’ll see which ones it used.
Source-linked intelligence
Related news
Silence Therapeutics prices $175M public offering at $13.50 per ADS — See source for full details.
Morgan Stanley maintains Overweight rating on Silence Therapeutics — See source for full details.
Silence Therapeutics earnings beat by $0.05, revenue fell short of estimates — See source for full details.
Silence Therapeutics launches $150 million public offering — See source for full details.
Silence Therapeutics stock surges as divesiran trial results fuel optimism — See source for full details.
Silence Therapeutics GAAP EPS of -$0.09 beats by $0.08 — See source for full details.
Why is Silence Therapeutics stock surging today? — See source for full details.
Loading $SLN research…